elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-38C7016C-CC8E-472A-B666-AB3D973CC1DE
Q27852097-38C7016C-CC8E-472A-B666-AB3D973CC1DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-38C7016C-CC8E-472A-B666-AB3D973CC1DE
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P304
Q27852097-38C7016C-CC8E-472A-B666-AB3D973CC1DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-38C7016C-CC8E-472A-B666-AB3D973CC1DE
rank
NormalRank
type
BestRank
Statement
P304
1232-43
http://www.w3.org/2001/XMLSchema#string